Form D — Cirrus Therapeutics, Inc.
0002070295-25-000002 · filed Aug 19, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $15,698,319
- Reported amount sold
- $6,698,321
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cirrus Therapeutics, Inc.
- CIK
- 2078601
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 750 Main Street
Cambridge, Massachusetts 02139 - Phone
- (617) 959-3124
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ying Kai Chan · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Andrew Dick · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Alexandra Cantley · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Khoo Shih · DirectorCambridge, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗